Current treatment of asthma--focus on leukotrienes (Q34181970)

31 July 2017

1 reference

title

Current treatment of asthma--focus on leukotrienes (English)

1 reference

31 July 2017

1 reference

Crowther SD

1

1 reference

31 July 2017

Rees PJ

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

1

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

1021-1040

1 reference

Mucosal inflammation in asthma

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

The eosinophil and the pathophysiology of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Phospholipase A2 enzymes: regulation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

On the nature of the 5-lipoxygenase reaction in human leukocytes: enzyme purification and requirement for multiple stimulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Influx of extracellular calcium is required for the membrane translocation of 5-lipoxygenase and leukotriene synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Purification of human leukotriene C4 synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Human alveolar macrophages produce leukotriene B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Leukotriene generation by eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

The eosinophil and bronchial asthma: current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Chemokinetic activity of arachidonic acid lipoxygenase products on leuocyctes of different species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Cysteinyl leukotrienes in asthma: old mediators up to new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Mechanism of aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Leukotriene-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Testing for human immunodeficiency virus infection in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

Leukotrienes are potent constrictors of human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1021

10.1517/14656566.1.5.1021

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference